Cargando…
AP-1 confers resistance to anti-cancer therapy by activating XIAP
The underlying cause of treatment failure in many cancer patients is intrinsic and acquired resistance to chemotherapy. Recently, histone deacetylase (HDAC) inhibitors have developed into a promising cancer treatment. However, resistance mechanism induced by HDAC inhibitors remains largely unknown....
Autores principales: | Wang, Yuan, Wan, Guo-Hui, Wu, Ying-Min, Wang, Hong-Sheng, Wang, Hai-Fang, Zhang, Ge, Lu, Lin-Lin, Li, Zi-Qian, Chan, Ka-Ying, Zhou, Yan, Cai, Shao-Hui, Qi, Yi-Fei, Du, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865658/ https://www.ncbi.nlm.nih.gov/pubmed/29581832 http://dx.doi.org/10.18632/oncotarget.23897 |
Ejemplares similares
-
The long noncoding RNA XIAP-AS1 promotes XIAP transcription by XIAP-AS1 interacting with Sp1 in gastric cancer cells
por: Cai, Jun, et al.
Publicado: (2017) -
Elevated XIAP expression alone does not confer chemoresistance
por: Seeger, J M, et al.
Publicado: (2010) -
CCR7 mediates the TNF-α-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2 - AP-1” and “JNK - AP-1” pathways
por: Hong, HaiJie, et al.
Publicado: (2016) -
Down-regulation of XIAP enhances the radiosensitivity of esophageal cancer cells in vivo and in vitro
por: Wen, Xin, et al.
Publicado: (2017) -
Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE
por: Cheung, Chun Hei Antonio, et al.
Publicado: (2020)